Business Daily Media

The Times Real Estate

.

Gene Solutions Announces Publication of Ground-breaking Study on AI-Driven Tumor-Specific Methylation Atlas

HO CHI MINH, VIETNAM - Media OutReach Newswire - 9 August 2024 - Gene Solutions, a pioneering genetic testing company in South-East Asia, is excited to announce the publication of a new peer-reviewed study that validates the analytical capabilities of its innovative, AI-driven Tumor-Specific Methylation Atlas (TSMA).

The study, published in BMC Journal of Translational Medicine: "Tissue of origin detection (TOO) for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks", details the robust analytical validation process which leverages advanced artificial intelligence to deliver precise and reliable tumor origin predictions in multi-cancer early detection.

Gene Solutions Announces Publication of Ground-breaking Study on AI-Driven Tumor-Specific Methylation Atlas

Firstly, the bioinformatics team from Gene Solutions used whole-genome bisulfite sequencing (WGBS) on five types of tumor tissues (breast, colorectal, gastric, liver and lung cancer) and paired white blood cells (WBC) to construct a tumor-specific methylation atlas (TSMA), where 2,945 CpG regions are discovered between tumor types and WBC. The team then implemented a Deep Learning model of Graph Convolutional Neural Network that combines deconvolution scores from the TSMA with other features to achieve an improved tumor of origin prediction accuracy in the validation dataset of 239 low-depth cfDNA samples.

By enhancing the accuracy of tumor identification through AI-driven method, the study opens up mutliple promises when applying in multi-cancer early detection tests:

Improved Data Accuracy: The combination demonstrated exceptional performance in accurately identifying the tumor of origin, notably up to 100%, 98% and 93% accuracies for breast, liver and colorectal cancer.

Reduced Sequencing Depth: By having a guiding atlas, the R&D team can optimize sequencing depth required for tumor identification, making it more efficient and cost-effective. This reduction in sequencing depth not only accelerates the time-to-result but also conserves costly next-generation sequencing resources.

Optimized Analysis Resources: The AI-driven approach optimizes the use of computational resources, reducing the overall cost and time required for tumor analysis. This optimization is a crucial step towards making advanced circulating tumor DNA analysis accessible and affordable for healthcare providers and patients alike.

Dr. Minh Duy Phan, a lead author of the study commented: "The analytical validation of the new tumor methylation atlas and deep learning algorithm marks a significant milestone in circulating tumor DNA analysis for early cancer signal detection. By harnessing the power of AI, we are enhancing the accuracy and efficiency of multi-cancer early detection technology for real-world utility."

Future Developments:

With further development by our data team, Gene Solutions is committed to expanding the capabilities of the TSMA. The ongoing research and development efforts aim to enable better quality analysis and application in real-life practice to reduce the cost of assays, ensuring that cutting-edge cancer screening tools are within reach for recommended individuals worldwide.

For more in-depth information about the study and the TSMA, please visit https://spotmas.com/blog/pioneering-a-tumor-specific-methylation-atlas-tsma-to-identify-tissue-of-origin-too-in-multi-cancer-early-detection/

References:

Nguyen, T.H., Doan, N.N.T., Tran, T.H. et al. Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks. J Transl Med 22, 618 (2024), doi: 10.1186/s12967-024-05416-z

Hashtag: #GeneSolutions

The issuer is solely responsible for the content of this announcement.

About Gene Solutions:

Gene Solutions, a pioneering genetic testing company in South-East Asia, empowers healthcare decisions by providing accessible and critical insights. Their services include next-generation sequencing (NGS) tests that support reproductive health and clinical oncology. Gene Solutions specializes in non-invasive prenatal screening (NIPT), minimal residual disease (MRD) monitoring, multi-gene panel liquid biopsy, comprehensive genomic profiling (CGP), and multi-cancer early detection (MCED) tests. Leveraging clinically validated cell-free DNA analysis methods and artificial intelligence applications in bioinformatics, the company is committed to enable precision medicine. With a network of six international standard NGS Laboratories across Southeast Asia, Gene Solutions remains at the forefront of innovative genetic solutions.

News from Asia

Galaxy Macau Celebrates 34 Awards, Continuing Its Ongoing Legacy of Luxury in Tourism and Leisure

MACAU SAR - Media OutReach Newswire - 17 January 2025 - As the world step into 2025, Galaxy Macau™, the world-class luxury integrated resort (hereafter referred to as "Galaxy Macau"), has proudly ...

The Functional Foods for Wellness Summit BKK 2025 concluded successfully in Bangkok, Thailand, on January 16th

BANGKOK, THAILAND - Media OutReach Newswire – 17 January 2025 - The Functional Foods for Wellness Summit BKK 2025 concluded successfully in Bangkok, Thailand, on January 16th. The summit received ...

1st APAC Intelligent Finance Forum and "Embarking on Prosperity Journey Together" Partnership Convention Concluded Successfully in Hong Kong

HONG KONG SAR - Media OutReach Newswire - 17 January 2025 - On January 16, 2025, the 1st APAC Intelligent Finance Forum, hosted by the Global Corporate Scale Management Association and co-organ...

CUHK: The influential academic leader in the world

HONG KONG SAR - Media OutReach - 15 November 2021 - Established in 1963 and still expanding, The Chinese University of Hong Kong (CUHK) is ranked among the best research universities internationall...

Nomination period for the Broermann Medical Innovation Award started

Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine Award honors researchers worldwide who have done pioneering work in medicine, biotech...

Galaxy Macau Collaborates with "Luzhou Laojiao · Guojiao 1573" Spring Festival Tasting Pop-Up Store Debuts

Experience Exclusive 2025 Yisi Snake Year Baijiu at Galaxy Macau Until March 31, 2025 MACAU SAR - Media OutReach Newswire - 18 January 2025 - In the spirit of the Lunar New Year, the world-class ...

VinFast officially enters the Indian market with the launch of the VF 6 and VF 7

NEW DELHI, INDIA - Media OutReach Newswire - 18 January 2025 - VinFast officially announces its first electric vehicles for the Indian market at the Bharat Mobility Global Exp...

Kim Yew Integrated Celebrates 40 Years With $68,000 Donation To The Business Times Budding Artists Fund

SINGAPORE - Media OutReach Newswire - 20 January 2025 - Led by a new management and board since 2021, Kim Yew Integrated marked its 40th anniversary with a $68,000 donation to The Business Times B...

Trend Micro is Recognized as a 2024 Gartner® Peer Insights™ Customers’ Choice for Cloud-Native Application Protection Platforms

The Gartner® Peer Insights™ Customers' Choice Distinction is based on feedback and ratings from end-user professionals who have experience with the product or service HONG KONG SAR - Media OutReac...

Wildberries Expands AI-Based Tools for Marketplace Users

MOSCOW, RUSSIA - Media OutReach Newswire - 20 January 2024 - Wildberries, one of the largest e-commerce platforms in Eurasia, has expanded its use of artificial intelligence (AI) to enhance the us...

Retailers combat post-Christmas debt and boost revenue amid changing customer behaviours

As the festive season wraps up, Australian retailers and companies are shifting their focus from holiday sales to addressing the challenges of pos...

When Will Infrastructure Companies See Gains from Generative AI?

A lot of questions are swirling about the state of generative AI right now. How far along are companies with their bespoke GenAI efforts? Are orga...

DLPA partners with Crestcom to bring its leadership training solutions

Dynamic Leadership Programs Australia (DLPA), a leading provider of leadership training and workforce strategy solutions, has joined forces with r...

Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025

Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia, has unv...

UBH Group Pioneers Australia's Path to Nuclear Sovereignty

Sovereign technology company, UBH Group, has achieved a landmark milestone as the first organisation in the Southern Hemisphere to secure ISO 1944...

The unsung heroes: How MSPs can safeguard SMBs while boosting profitability

In Australia, small-to-medium-sized businesses (SMBs) form the backbone of the economy, accounting for 95% of all businesses. Yet, they remain pri...

Sell by LayBy